3,4-dihydroxyphenylacetic acid has been researched along with 1-naphthylamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cespuglio, R; Debilly, G; Jouvet, M; Marinesco, S; Poncet, L | 1 |
| Brannan, T; Di Rocco, A; Prikhojan, A; Yahr, MD | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 1-naphthylamine
| Article | Year |
|---|---|
Effects of tianeptine, sertraline and clomipramine on brain serotonin metabolism: a voltammetric approach in the rat.
Topics: 1-Naphthylamine; 3,4-Dihydroxyphenylacetic Acid; Allylamine; Animals; Antidepressive Agents; Brain; Clomipramine; Clorgyline; Electrochemistry; Hydroxyindoleacetic Acid; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Rats; Rats, Inbred Strains; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Thiazepines | 1996 |
Sertraline induced parkinsonism. A case report and an in-vivo study of the effect of sertraline on dopamine metabolism.
Topics: 1-Naphthylamine; 3,4-Dihydroxyphenylacetic Acid; Aged; Animals; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Microdialysis; Neostriatum; Parkinson Disease, Secondary; Rats; Sertraline | 1998 |